KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Hims & Hers Health (HIMS) EBIT Margin: 2020-2025

Historic EBIT Margin for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to 1.97%.

  • Hims & Hers Health's EBIT Margin fell 360.00% to 1.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.20%, marking a year-over-year increase of 175.00%. This contributed to the annual value of 4.19% for FY2024, which is 757.00% up from last year.
  • Per Hims & Hers Health's latest filing, its EBIT Margin stood at 1.97% for Q3 2025, which was down 59.81% from 4.90% recorded in Q2 2025.
  • Hims & Hers Health's EBIT Margin's 5-year high stood at 9.88% during Q1 2025, with a 5-year trough of -92.54% in Q1 2021.
  • For the 3-year period, Hims & Hers Health's EBIT Margin averaged around 1.72%, with its median value being 3.49% (2024).
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by 7,185bps in 2021, then soared by 7,584bps in 2022.
  • Hims & Hers Health's EBIT Margin (Quarterly) stood at -25.46% in 2021, then spiked by 1,852bps to -6.94% in 2022, then skyrocketed by 678bps to -0.16% in 2023, then surged by 403bps to 3.86% in 2024, then tumbled by 360bps to 1.97% in 2025.
  • Its last three reported values are 1.97% in Q3 2025, 4.90% for Q2 2025, and 9.88% during Q1 2025.